Political spending will spike next year, but stations will struggle to reverse a longstanding shift away from local TV ...

The media landscape can change in a snap. A new social media platform could explode in popularity, or a shift in consumer ...

Breakthrough TV creative continues to spark search demand. Learn what top ads reveal about emotion, attention, and user behavior.

With viewership data underpinning $60 billion in television advertising, an industry behemoth is suddenly facing questions about whether it is “bringing an abacus to an AI fight.” Pacing the stage at ...

After spending much of the year sloping steadily downward from a January peak, TV drug ad spending picked up in a major way last month. The combined outlay for the top 10 brands in October weighed in ...

The deployment makes it possible for advertisers to execute video ad campaigns in a CTV-like manner using traditional TV ad inventory, the two companies said. When you purchase through links on our ...

This is the first time Pinterest has wedded its intent-based audience data with a CTV engine, pointing to the growing ...

For all the talk of social media dominance and short-form content, television advertising still has an oddly persistent hold over us. There’s something about the combination of sound, visuals and ...

An effort by President Trump’s administration to curb advertising for pharmaceutical drugs on television is posing a potential marketing hurdle for some of the country’s largest drugmakers while ...

The global retail media market retains significant momentum, with ad investment projected to surpass $200 billion (€173.8bn) by 2027, reports WARC Media. However, underlying this growth is an evolving ...

Though spending on pharmaceutical TV ads picked up last month following a summer slump, the third quarter’s overall total still paled in comparison to the preceding periods this year. In Q3, the top ...

The administration is proposing a return to a 1990s-era policy that kept most drug ads off TV. That could dent the revenues of drugmakers and major networks. By Rebecca Robbins Christina Jewett and ...